The North America Nanotechnology Drug Delivery Market would witness market growth of 8.1% CAGR during the forecast period (2023-2030).
Nanotechnology has emerged as a revolutionary paradigm in drug delivery, ushering in a new era of precision, efficiency, and targeted therapeutic interventions. Integrating nanoscale materials and technologies into drug delivery systems has opened avenes for overcoming longstanding challenges in the pharmaceutical industry, offering solutions to enhance drug bioavailability, improve targeting, and minimize side effects. The market has recently experienced substantial expansion and acceptance, propelled by the unwavering quest for novel approaches to tackle the intricate challenges of contemporary healthcare.
In addition, the adoption of nanotechnology in drug delivery has been a transformative force in the pharmaceutical landscape. The urgency to maximize the therapeutic efficacy of drugs, particularly in the treatment of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions, is driving this adoption. Conventional drug delivery methods often face limitations related to poor solubility, non-specific distribution, and systemic toxicity. Nanotechnology offers a promising avenue to overcome these challenges, providing a platform for designing and engineering nanocarriers that can encapsulate and transport drugs with unprecedented precision.
The United States is a hub for nanotechnology research and development, and advancements in this field directly affect drug delivery. Researchers are exploring nanoscale drug carriers, such as nanoparticles and liposomes, which can enhance drug solubility, stability, and targeted delivery to specific cells or tissues. The U.S. government provides significant funding and support for nanotechnology research through agencies like the National Nanotechnology Initiative (NNI). As per the data from the National Nanotechnology Initiative of the United States, the 2022 economic impact of nanotechnology on the U.S. economy was between $67 billion and $83 billion, which is close to a trillion dollars over the past two decades. Thus, the rising nanotechnology sector in North America will help expand the regional market.
The US market dominated the North America Nanotechnology Drug Delivery Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $47,618.9 Million by 2030. The Canada market is experiencing a CAGR of 10.5% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 9.6% during (2023 - 2030).
Free Valuable Insights: The Nanotechnology Drug Delivery Market is Predict to reach USD 153 Billion by 2030, at a CAGR of 8.7%
Based on Formulation, the market is segmented into Polymer-Based Nanomedicine, Lipid-Based Nanomedicine, Nanocrystals, and Others. Based on Application, the market is segmented into Oncology & Hematology, Infectious Diseases, Orthopedics, Neurology, Immunology, Urology, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- AbbVie, Inc.
- Pfizer Inc.
- Johnson & Johnson (Johnson & Johnson Services, Inc.)
- Novartis AG
- Bristol-Myers Squibb Company
- AstraZeneca PLC
- Amgen, Inc.
- Merck KGaA
- Teva Pharmaceutical Industries Ltd.
- Sanofi S.A.
North America Nanotechnology Drug Delivery Market Report Segmentation
By Formulation
- Polymer-Based Nanomedicine
- Lipid-Based Nanomedicine
- Nanocrystals
- Others
By Application
- Oncology & Hematology
- Infectious Diseases
- Orthopedics
- Neurology
- Immunology
- Urology
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Nanotechnology Drug Delivery Market, by Formulation
1.4.2 North America Nanotechnology Drug Delivery Market, by Application
1.4.3 North America Nanotechnology Drug Delivery Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis
Chapter 4. North America Nanotechnology Drug Delivery Market, by Formulation
4.1 North America Polymer-Based Nanomedicine Market, by Country
4.2 North America Lipid-Based Nanomedicine Market, by Country
4.3 North America Nanocrystals Market, by Country
4.4 North America Others Market, by Country
Chapter 5. North America Nanotechnology Drug Delivery Market, by Application
5.1 North America Oncology & Hematology Market, by Country
5.2 North America Infectious Diseases Market, by Country
5.3 North America Orthopedics Market, by Country
5.4 North America Neurology Market, by Country
5.5 North America Immunology Market, by Country
5.6 North America Urology Market, by Country
5.7 North America Others Market, by Country
Chapter 6. North America Nanotechnology Drug Delivery Market, by Country
6.1 US Nanotechnology Drug Delivery Market
6.1.1 US Nanotechnology Drug Delivery Market, by Formulation
6.1.2 US Nanotechnology Drug Delivery Market, by Application
6.2 Canada Nanotechnology Drug Delivery Market
6.2.1 Canada Nanotechnology Drug Delivery Market, by Formulation
6.2.2 Canada Nanotechnology Drug Delivery Market, by Application
6.3 Mexico Nanotechnology Drug Delivery Market
6.3.1 Mexico Nanotechnology Drug Delivery Market, by Formulation
6.3.2 Mexico Nanotechnology Drug Delivery Market, by Application
6.4 Rest of North America Nanotechnology Drug Delivery Market
6.4.1 Rest of North America Nanotechnology Drug Delivery Market, by Formulation
6.4.2 Rest of North America Nanotechnology Drug Delivery Market, by Application
Chapter 7. Company Profiles
7.1 AbbVie, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Acquisition and Mergers:
7.1.6 SWOT Analysis
7.2 Pfizer, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional & Segmental Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.2.6 SWOT Analysis
7.3 Johnson & Johnson
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental &Regional Analysis
7.3.4 SWOT Analysis
7.4 Novartis AG
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 SWOT Analysis
7.5 Bristol-Myers Squibb Company
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.6 SWOT Analysis
7.6 AstraZeneca PLC
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 SWOT Analysis
7.7 Amgen, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 SWOT Analysis
7.8 Merck KGaA
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and Mergers:
7.8.6 SWOT Analysis
7.9 Teva Pharmaceutical Industries Ltd.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 SWOT Analysis
7.10. Sanofi S.A.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 SWOT Analysis
TABLE 1 North America Nanotechnology Drug Delivery Market, 2019 - 2022, USD Million
TABLE 2 North America Nanotechnology Drug Delivery Market, 2023 - 2030, USD Million
TABLE 3 North America Nanotechnology Drug Delivery Market, by Formulation, 2019 - 2022, USD Million
TABLE 4 North America Nanotechnology Drug Delivery Market, by Formulation, 2023 - 2030, USD Million
TABLE 5 North America Polymer-Based Nanomedicine Market, by Country, 2019 - 2022, USD Million
TABLE 6 North America Polymer-Based Nanomedicine Market, by Country, 2023 - 2030, USD Million
TABLE 7 North America Lipid-Based Nanomedicine Market, by Country, 2019 - 2022, USD Million
TABLE 8 North America Lipid-Based Nanomedicine Market, by Country, 2023 - 2030, USD Million
TABLE 9 North America Nanocrystals Market, by Country, 2019 - 2022, USD Million
TABLE 10 North America Nanocrystals Market, by Country, 2023 - 2030, USD Million
TABLE 11 North America Others Market, by Country, 2019 - 2022, USD Million
TABLE 12 North America Others Market, by Country, 2023 - 2030, USD Million
TABLE 13 North America Nanotechnology Drug Delivery Market, by Application, 2019 - 2022, USD Million
TABLE 14 North America Nanotechnology Drug Delivery Market, by Application, 2023 - 2030, USD Million
TABLE 15 North America Oncology & Hematology Market, by Country, 2019 - 2022, USD Million
TABLE 16 North America Oncology & Hematology Market, by Country, 2023 - 2030, USD Million
TABLE 17 North America Infectious Diseases Market, by Country, 2019 - 2022, USD Million
TABLE 18 North America Infectious Diseases Market, by Country, 2023 - 2030, USD Million
TABLE 19 North America Orthopedics Market, by Country, 2019 - 2022, USD Million
TABLE 20 North America Orthopedics Market, by Country, 2023 - 2030, USD Million
TABLE 21 North America Neurology Market, by Country, 2019 - 2022, USD Million
TABLE 22 North America Neurology Market, by Country, 2023 - 2030, USD Million
TABLE 23 North America Immunology Market, by Country, 2019 - 2022, USD Million
TABLE 24 North America Immunology Market, by Country, 2023 - 2030, USD Million
TABLE 25 North America Urology Market, by Country, 2019 - 2022, USD Million
TABLE 26 North America Urology Market, by Country, 2023 - 2030, USD Million
TABLE 27 North America Others Market, by Country, 2019 - 2022, USD Million
TABLE 28 North America Others Market, by Country, 2023 - 2030, USD Million
TABLE 29 North America Nanotechnology Drug Delivery Market, by Country, 2019 - 2022, USD Million
TABLE 30 North America Nanotechnology Drug Delivery Market, by Country, 2023 - 2030, USD Million
TABLE 31 US Nanotechnology Drug Delivery Market, 2019 - 2022, USD Million
TABLE 32 US Nanotechnology Drug Delivery Market, 2023 - 2030, USD Million
TABLE 33 US Nanotechnology Drug Delivery Market, by Formulation, 2019 - 2022, USD Million
TABLE 34 US Nanotechnology Drug Delivery Market, by Formulation, 2023 - 2030, USD Million
TABLE 35 US Nanotechnology Drug Delivery Market, by Application, 2019 - 2022, USD Million
TABLE 36 US Nanotechnology Drug Delivery Market, by Application, 2023 - 2030, USD Million
TABLE 37 Canada Nanotechnology Drug Delivery Market, 2019 - 2022, USD Million
TABLE 38 Canada Nanotechnology Drug Delivery Market, 2023 - 2030, USD Million
TABLE 39 Canada Nanotechnology Drug Delivery Market, by Formulation, 2019 - 2022, USD Million
TABLE 40 Canada Nanotechnology Drug Delivery Market, by Formulation, 2023 - 2030, USD Million
TABLE 41 Canada Nanotechnology Drug Delivery Market, by Application, 2019 - 2022, USD Million
TABLE 42 Canada Nanotechnology Drug Delivery Market, by Application, 2023 - 2030, USD Million
TABLE 43 Mexico Nanotechnology Drug Delivery Market, 2019 - 2022, USD Million
TABLE 44 Mexico Nanotechnology Drug Delivery Market, 2023 - 2030, USD Million
TABLE 45 Mexico Nanotechnology Drug Delivery Market, by Formulation, 2019 - 2022, USD Million
TABLE 46 Mexico Nanotechnology Drug Delivery Market, by Formulation, 2023 - 2030, USD Million
TABLE 47 Mexico Nanotechnology Drug Delivery Market, by Application, 2019 - 2022, USD Million
TABLE 48 Mexico Nanotechnology Drug Delivery Market, by Application, 2023 - 2030, USD Million
TABLE 49 Rest of North America Nanotechnology Drug Delivery Market, 2019 - 2022, USD Million
TABLE 50 Rest of North America Nanotechnology Drug Delivery Market, 2023 - 2030, USD Million
TABLE 51 Rest of North America Nanotechnology Drug Delivery Market, by Formulation, 2019 - 2022, USD Million
TABLE 52 Rest of North America Nanotechnology Drug Delivery Market, by Formulation, 2023 - 2030, USD Million
TABLE 53 Rest of North America Nanotechnology Drug Delivery Market, by Application, 2019 - 2022, USD Million
TABLE 54 Rest of North America Nanotechnology Drug Delivery Market, by Application, 2023 - 2030, USD Million
TABLE 55 Key information – AbbVie, Inc.
TABLE 56 Key Information – Pfizer, Inc.
TABLE 57 Key Information – Johnson & Johnson
TABLE 58 Key Information – Novartis AG
TABLE 59 Key Information – Bristol-Myers Squibb Company
TABLE 60 KEY INFORMATION – AstraZeneca PLC
TABLE 61 Key Information – Amgen, Inc.
TABLE 62 key Information – Merck KGaA
TABLE 63 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 64 Key Information – Sanofi S.A.
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Nanotechnology Drug Delivery Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Nanotechnology Drug Delivery Market
FIG 4 Porter’s Five Forces Analysis - Nanotechnology Drug Delivery Market
FIG 5 North America Nanotechnology Drug Delivery Market share, by Formulation, 2022
FIG 6 North America Nanotechnology Drug Delivery Market share, by Formulation, 2030
FIG 7 North America Nanotechnology Drug Delivery Market, by Formulation, 2019 - 2030, USD Million
FIG 8 North America Nanotechnology Drug Delivery Market share, by Application, 2022
FIG 9 North America Nanotechnology Drug Delivery Market share, by Application, 2030
FIG 10 North America Nanotechnology Drug Delivery Market, by Application, 2019 - 2030, USD Million
FIG 11 North America Nanotechnology Drug Delivery Market share, by Country, 2022
FIG 12 North America Nanotechnology Drug Delivery Market share, by Country, 2030
FIG 13 North America Nanotechnology Drug Delivery Market, by Country, 2019 - 2030, USD Million
FIG 14 Swot Analysis: AbbVie, Inc.
FIG 15 SWOT Analysis: Pfizer, Inc.
FIG 16 SWOT Analysis: Johnson & Johnson
FIG 17 SWOT Analysis: Novartis AG
FIG 18 SWOT Analysis: Bristol-Myers Squibb Company
FIG 19 SWOT Analysis: AstraZeneca PLC
FIG 20 Swot Analysis: Amgen, Inc.
FIG 21 Swot Analysis: Merck KGaA
FIG 22 SWOT Analysis: Teva Pharmaceuticals Industries Ltd.
FIG 23 Swot Analysis: Sanofi S.A.